Stay updated on Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial page.

Latest updates to the Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded a Locations section displaying the Houston, Texas site (MD Anderson Cancer Center). Removed the HHS Vulnerability Disclosure footer link and the Texas Locations label, and updated the page revision to v3.3.3.SummaryDifference0.2%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedFooter revision note updated from v3.2.0 to v3.3.2. This metadata change does not alter any study information or content.SummaryDifference0.1%

- Check54 days agoChange DetectedThe government funding/operating status notice was removed from the page; core trial information and study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check68 days agoChange DetectedMinor cosmetic updates to the Study Details page, including header layout and typography; core study data such as eligibility criteria, interventions, and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check97 days agoChange DetectedAdded a critical funding-status notice and updated version to v3.2.0, while removing the previous v3.1.0 tag; conveys that some information may be out-of-date and provides official status sources.SummaryDifference4%

- Check104 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes are evident.SummaryDifference0.1%

Stay in the know with updates to Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial page.